4.56
                                            전일 마감가:
              $4.75
            열려 있는:
              $4.71
            하루 거래량:
                841.06K
            Relative Volume:
              1.38
            시가총액:
                $441.77M
            수익:
              -
            순이익/손실:
              $-238.77M
            주가수익비율:
              -0.1701
            EPS:
                -26.808
            순현금흐름:
                $-216.62M
            1주 성능:
              -5.20%
            1개월 성능:
              +13.43%
            6개월 성능:
                -0.65%
            1년 성능:
              -59.68%
            Alumis Inc Stock (ALMS) Company Profile
명칭
                  
                      Alumis Inc
                    
                전화
                  
                      650-231-6625
                    
                주소
                  
                      280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
                    
                ALMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ALMS
                            
                             
                        Alumis Inc 
                           | 
                    4.56 | 494.31M | 0 | -238.77M | -216.62M | -26.81 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-07-25 | 개시 | Wells Fargo | Overweight | 
| 2025-06-10 | 재개 | Guggenheim | Buy | 
| 2025-01-30 | 개시 | Oppenheimer | Outperform | 
| 2024-10-31 | 개시 | Robert W. Baird | Outperform | 
| 2024-10-17 | 개시 | H.C. Wainwright | Buy | 
| 2024-07-23 | 개시 | Cantor Fitzgerald | Overweight | 
| 2024-07-23 | 개시 | Guggenheim | Buy | 
| 2024-07-23 | 개시 | Leerink Partners | Outperform | 
| 2024-07-23 | 개시 | Morgan Stanley | Overweight | 
                    모두보기
                    
                  
                Alumis Inc 주식(ALMS)의 최신 뉴스
Is a relief rally coming for Alumis Inc. holdersQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alumis Inc 주식 (ALMS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 | 
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director  | 
                        May 06 '25  | 
                        Buy  | 
                        4.34  | 
                        20,000  | 
                        86,800  | 
                        4,247,670  | 
                    
| Foresite Labs, LLC | 10% Owner  | 
                        May 02 '25  | 
                        Buy  | 
                        4.62  | 
                        25,000  | 
                        115,500  | 
                        4,227,670  | 
                    
| Foresite Labs, LLC | 10% Owner  | 
                        May 06 '25  | 
                        Buy  | 
                        4.34  | 
                        20,000  | 
                        86,800  | 
                        4,247,670  | 
                    
| Foresite Capital Management VI | 10% Owner  | 
                        May 02 '25  | 
                        Buy  | 
                        4.62  | 
                        25,000  | 
                        115,500  | 
                        4,227,670  | 
                    
| Foresite Capital Management VI | 10% Owner  | 
                        May 06 '25  | 
                        Buy  | 
                        4.34  | 
                        20,000  | 
                        86,800  | 
                        4,247,670  | 
                    
| AKKARAJU SRINIVAS | Director  | 
                        May 05 '25  | 
                        Buy  | 
                        4.67  | 
                        160,370  | 
                        749,676  | 
                        3,586,788  | 
                    
| AKKARAJU SRINIVAS | Director  | 
                        May 02 '25  | 
                        Buy  | 
                        4.55  | 
                        159,920  | 
                        727,636  | 
                        3,426,418  | 
                    
| Colowick Alan | Director  | 
                        Apr 01 '25  | 
                        Buy  | 
                        6.97  | 
                        16,104  | 
                        112,309  | 
                        16,104  | 
                    
| Colowick Alan | Director  | 
                        Apr 02 '25  | 
                        Buy  | 
                        7.49  | 
                        2,300  | 
                        17,235  | 
                        18,404  | 
                    
| Babler Martin | President, CEO and Chairman  | 
                        Apr 01 '25  | 
                        Buy  | 
                        6.44  | 
                        15,650  | 
                        100,733  | 
                        106,454  | 
                    
                자본화:
                 
                  | 
                볼륨(24시간):